NVO shares near highs up nearly 3% after WSJ noted overnight the launch of weight-loss pills is the hottest battle in Pharma. So far, LLY El
NVO shares near highs up nearly 3% after WSJ noted overnight the launch of weight-loss pills is the hottest battle in Pharma. So far, LLY Eli Lilly is losing to rival Novo Nordisk Link To Story from WSJ.com
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.